ORMP
Oramed Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.01
+1.62%Jul 7, 2026, 00:00 UTC
Lifeward Ltd. signed a securities purchase agreement to issue up to $11.16 million aggregate principal amount of senior secured convertible notes, with $5.58 million issued at closing on July 6, 2026, and the remainder subject to conditions.
Jun 25, 2026, 15:35 UTC
Scilex loan was substantially repaid to Oramed Pharmaceuticals.
Source:Jun 17, 2026, 00:00 UTC
Oramed Pharmaceuticals Inc. disclosed a 7.2% stake in Nano Dimension Ltd. via a 13D/G filing.